Introduction
Tolosa Hunt Syndrome (THS) is a idiopathic inflammatory granulomatous condition affecting the cavernous sinus and/or orbital apex causing painful ophthalmoplegia. It is a rare syndrome affecting 1 person per million per year. We present a rare case of THS resulting in hypopituitarism.
Background
Initially described by Tolosa 1 in 1954 and expanded upon by Hunt 2 in 1961 the condition is unilateral, but can be bilateral and is strongly associated with periorbital headaches and pain. Patients exhibit paralysis of the III, IV, or VI cranial nerves and are often noted to have proptosis and/or a dilated pupil.
The diagnosis of THS has to be made following clinical evaluation and neuroimaging. There are many other causes for compressive lesions in the cavernous sinus, notably aneurysm, fistula, neoplasia, thrombosis or lymphoma, that can cause the same clinical presentation which have to be ruled out prior to the the diagnosis of THS. The International Headache Society supplied a specific diagnostic criteria for THS (Table 1) .
If left untreated THS usually spontaneously resolves after about two months but is normally highly responsive to glucocorticoids when given. It is considered a benign condition but rarely has been known to cause permanent neurological deficits and cause hypopituitarism.
Case
A 45-year-old female presented with a ten day history of headache, periorbital pain and diplopia. Her past medical history included bipolar disorder and bilateral below knee amputation from rail accident. She took mirtazepine, olanzapine and epilim for bipolar.
On examination, a left abducens nerve palsy was noted with no other neurological or ophthalmological abnormalities. Haematology, biochemistry, autoimmune screen, angiotensin converting enzyme (ACE) were normal. MR angiography showed a hyper-intense lesion in the left of the cavernous sinus suggesting inflammatory tissue, but no vascular or pituitary abnormalities noted. (Fig. 1) A diagnosis of THS was made, and prednisolone 60mg/day was commenced. Ophthalmic pain subsided within 48 hours; ophthalmoplegia resolved over 3 months leading to steroid cessation. 
Progression
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